Published in Oncology on January 01, 1982
Phosphoglycerate mutase, 2,3-bisphosphoglycerate phosphatase, creatine kinase and enolase activity and isoenzymes in breast carcinoma. Br J Cancer (2000) 1.00
Simultaneous and sequential determinations of steroid hormone receptors in human breast cancer. Influence of intervening therapy. Ann Surg (1985) 0.94
Comparison of Predictive Immunohistochemical Marker Expression of Primary Breast Cancer and Paired Distant Metastasis using Surgical Material: A Practice-Based Study. J Histochem Cytochem (2016) 0.80
Reduction in new metastases in breast cancer with adjuvant clodronate treatment. N Engl J Med (1998) 6.09
Transient neurologic toxicity after hyperbaric subarachnoid anesthesia with 5% lidocaine. Anesth Analg (1993) 4.24
Goserelin versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer: The Zoladex Early Breast Cancer Research Association Study. J Clin Oncol (2002) 2.61
Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status. J Natl Cancer Inst (1996) 2.51
Widespread intraspecies cross-contamination of human tumor cell lines arising at source. Int J Cancer (1999) 2.20
Characterization of breast carcinomas by two monoclonal antibodies distinguishing myoepithelial from luminal epithelial cells. J Histochem Cytochem (1986) 2.05
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials. Lancet (2015) 2.05
The principal neutralization determinant of simian immunodeficiency virus differs from that of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A (1992) 2.00
In vivo chemosensitivity-adapted preoperative chemotherapy in patients with early-stage breast cancer: the GEPARTRIO pilot study. Ann Oncol (2005) 1.89
Endocrine treatment options for advanced breast cancer--the role of fulvestrant. Eur J Cancer (2005) 1.65
Growth rate of 147 mammary carcinomas. Cancer (1980) 1.62
Ectopic growth of endometrium depends on its structural integrity and proteolytic activity in the cynomolgus monkey (Macaca fascicularis) model of endometriosis. Fertil Steril (1996) 1.56
BioMiner--modeling, analyzing, and visualizing biochemical pathways and networks. Bioinformatics (2002) 1.55
Monoclonal immunoglobulin A antibody directed against serotype-specific epitope of Shigella flexneri lipopolysaccharide protects against murine experimental shigellosis. J Exp Med (1995) 1.54
Multicenter phase II study of oral capecitabine (Xeloda(")) in patients with metastatic breast cancer relapsing after treatment with a taxane-containing therapy. Ann Oncol (2003) 1.53
Pretherapeutic detection of tumour resistance and the results of tumour chemotherapy. Eur J Cancer (1979) 1.49
Cytokine release from placental endothelial cells, a process associated with preterm labour in the absence of intrauterine infection. Cytokine (1999) 1.44
The pH as an important determinant of sperm-mucus interaction. Fertil Steril (1993) 1.43
Melanoma-inhibiting activity, a novel serum marker for progression of malignant melanoma. Cancer Res (1997) 1.42
Nitrous oxide is a potent cerebrovasodilator in humans when added to isoflurane. A transcranial Doppler study. Acta Anaesthesiol Scand (1995) 1.40
P-glycoprotein expression in treated and untreated human breast cancer. Br J Cancer (1989) 1.39
Detection of tumor cells in bone marrow of patients with primary breast cancer: a prognostic factor for distant metastasis. J Clin Oncol (1992) 1.32
Beta-galactoside-binding protein secreted by activated T cells inhibits antigen-induced proliferation of T cells. Eur J Immunol (1998) 1.27
Stable gene silencing of cyclin B1 in tumor cells increases susceptibility to taxol and leads to growth arrest in vivo. Oncogene (2006) 1.24
Augmentation of mechanical properties in osteoporotic vertebral bones--a biomechanical investigation of vertebroplasty efficacy with different bone cements. Eur Spine J (2001) 1.24
[Histologic regression of breast cancer after primary (neoadjuvant) chemotherapy]. Geburtshilfe Frauenheilkd (1994) 1.22
Pegfilgrastim +/- ciprofloxacin for primary prophylaxis with TAC (docetaxel/doxorubicin/cyclophosphamide) chemotherapy for breast cancer. Results from the GEPARTRIO study. Ann Oncol (2007) 1.22
Temporal hemodynamic effects of permissive hypercapnia associated with ideal PEEP in ARDS. Am J Respir Crit Care Med (1997) 1.21
HLXB9 activates IL6 in Hodgkin lymphoma cell lines and is regulated by PI3K signalling involving E2F3. Leukemia (2005) 1.21
Comparison of immunohistochemistry and RT-PCR for detection of CD44v-expression, a new prognostic factor in human breast cancer. Int J Cancer (1995) 1.20
Binding of inositol phosphates and induction of Ca2+ release from pituitary microsomal fractions. Biochem J (1987) 1.20
Surface protein expression and messenger RNA-splicing analysis of CD44 in uterine cervical cancer and normal cervical epithelium. Cancer Res (1994) 1.19
Differential diagnosis of benign epithelial proliferations and carcinomas of the breast using antibodies to cytokeratins. Hum Pathol (1988) 1.19
The gene map of the Norway rat (Rattus norvegicus) and comparative mapping with mouse and man. Genomics (1991) 1.19
Gene expression of topoisomerase II alpha (TOP2A) by microarray analysis is highly prognostic in estrogen receptor (ER) positive breast cancer. Breast Cancer Res Treat (2008) 1.17
Goserelin depot in the treatment of premenopausal advanced breast cancer. Eur J Cancer (1992) 1.17
Breast cancer patients' expectations in respect of the physician-patient relationship and treatment management results of a survey of 617 patients. Ann Oncol (2007) 1.16
Central HER2 IHC and FISH analysis in a trastuzumab (Herceptin) phase II monotherapy study: assessment of test sensitivity and impact of chromosome 17 polysomy. J Clin Pathol (2007) 1.13
The anaesthesia critical incident reporting system: an experience based database. Int J Med Inform (1997) 1.12
Influence of severe obesity on peripheral hormone concentrations in pre- and postmenopausal women. Eur J Obstet Gynecol Reprod Biol (1983) 1.12
Virus-activated CD8 T cells and lymphokine-activated NK cells express the mast cell function-associated antigen, an inhibitory C-type lectin. J Immunol (1998) 1.11
Rational combinations of siRNAs targeting Plk1 with breast cancer drugs. Oncogene (2007) 1.11
A randomised study to compare the effect of the luteinising hormone releasing hormone (LHRH) analogue goserelin with or without tamoxifen in pre- and perimenopausal patients with advanced breast cancer. Eur J Cancer (1995) 1.11
Polo-like kinase: a novel marker of proliferation: correlation with estrogen-receptor expression in human breast cancer. Pathol Res Pract (2000) 1.10
Molecular classification of breast cancer patients by gene expression profiling. J Pathol (2001) 1.08
Diagnostic and therapeutic pleuroscopy. Experience with 127 patients. Chest (1980) 1.08
Calcitonin: regional distribution of the hormone and its binding sites in the human brain and pituitary. Proc Natl Acad Sci U S A (1981) 1.06
Impact of intrapartum monitoring on perinatal mortality and morbidity. Contrib Gynecol Obstet (1977) 1.05
Amplification at 7q22 targets cyclin-dependent kinase 6 in T-cell lymphoma. Leukemia (2007) 1.03
[The limits of hormone substitution in pollutant exposure and fertility disorders]. Zentralbl Gynakol (1992) 1.03
Factors influencing the prognostic role of oestrogen and progesterone receptor levels in breast cancer--results of the analysis of 670 patients with 11 years of follow-up. Eur J Cancer (2002) 1.03
Immunomorphological lymph node changes in patients with operable bronchogenic squamous cell carcinoma. Cancer (1977) 1.02
Dosage frequency and drug-compliance behaviour--a comparative study on compliance with a medication to be taken twice or four times daily. Eur J Clin Pharmacol (1991) 1.00
Rituximab consolidation after high-dose chemotherapy and autologous blood stem cell transplantation in follicular and mantle cell lymphoma: a prospective, multicenter phase II study. Ann Oncol (2004) 1.00
Repeated dural punctures increase the incidence of postdural puncture headache. Anesth Analg (1996) 0.99
Sperm morphology assessment using strict criteria and male fertility under in-vivo conditions of conception. Hum Reprod (1996) 0.99
International inter- and intrahospital patient spread of a multiple antibiotic-resistant strain of Klebsiella pneumoniae. J Infect Dis (1995) 0.99
Phase I/II study of capecitabine and vinorelbine in pretreated patients with metastatic breast cancer. Ann Oncol (2005) 0.99
Homeostatic regulation of CD8+ T cells after antigen challenge in the absence of Fas (CD95). Eur J Immunol (1996) 0.99
MEF2C is activated by multiple mechanisms in a subset of T-acute lymphoblastic leukemia cell lines. Leukemia (2007) 0.99
Correlation of DNA flow cytometric results and other prognostic factors in primary breast cancer. Int J Cancer (1988) 0.99
[Effect of the PGE1 methyl analog misoprostol on the pregnant uterus in the first trimester]. Geburtshilfe Frauenheilkd (1987) 0.98
Phase II study of gemcitabine as first-line chemotherapy in patients with advanced or metastatic breast cancer. Anticancer Drugs (1999) 0.98
Cleavage of human and mouse cytoskeletal and sarcomeric proteins by human immunodeficiency virus type 1 protease. Actin, desmin, myosin, and tropomyosin. Am J Pathol (1993) 0.98
[Selective tumour chemotherapy using oncobiograms (author's transl)]. Dtsch Med Wochenschr (1974) 0.97
[Light and electron microscopy changes in the endometrium caused by the administration of a norgestimate-containing oral contraceptive (Cilest)]. Geburtshilfe Frauenheilkd (1986) 0.97
Karyotypic dissection of Hodgkin's disease cell lines reveals ectopic subtelomeres and ribosomal DNA at sites of multiple jumping translocations and genomic amplification. Leukemia (2000) 0.97
Adhesion induced expression of the serine/threonine kinase Fnk in human macrophages. Oncogene (2000) 0.97
Survival data relating to the use of goserelin depot in the treatment of premenopausal advanced breast cancer. Eur J Cancer (1993) 0.96
Meta-analysis of trials comparing toremifene with tamoxifen and factors predicting outcome of antiestrogen therapy in postmenopausal women with breast cancer. Breast Cancer Res Treat (1999) 0.96
Methylation of estrogen receptor beta promoter correlates with loss of ER-beta expression in mammary carcinoma and is an early indication marker in premalignant lesions. Endocr Relat Cancer (2005) 0.96
Allelic imbalance on chromosome 13q: evidence for the involvement of BRCA2 and RB1 in sporadic breast cancer. Cancer Res (1996) 0.96
[Significance of the examination position in urodynamic assessment of female urinary incontinence]. Geburtshilfe Frauenheilkd (1987) 0.95
Protection against invasion of the mouse pulmonary epithelium by a monoclonal IgA directed against Shigella flexneri lipopolysaccharide. Ann N Y Acad Sci (1994) 0.95
An efficient algorithm for finding short approximate non-tandem repeats. Bioinformatics (2001) 0.95
Chlorinated hydrocarbons in women with repeated miscarriages. Environ Health Perspect (1998) 0.95
Effect of inositol 1,4,5-trisphosphate and GTP on calcium release from pituitary microsomes. FEBS Lett (1987) 0.95
Neuroendocrine changes in patients with acute space occupying ischaemic stroke. J Neurol Neurosurg Psychiatry (2003) 0.95
Maximized reduction of primary breast tumor size using preoperative chemotherapy with doxorubicin and docetaxel. J Clin Oncol (1999) 0.94
Comparison of guided insertion of the LMA ProSeal vs the i-gel. Anaesthesia (2010) 0.94
Heavy metals and fertility. J Toxicol Environ Health A (1998) 0.94
Control of a nosocomial outbreak of vancomycin resistant Enterococcus faecium in a paediatric oncology unit: risk factors for colonisation. Eur J Pediatr (1998) 0.94
Predictive value of serum interleukin-6 and -8 levels in preterm labor or rupture of the membranes. Acta Obstet Gynecol Scand (2000) 0.94
Characterization of binding sites for a GnRH-agonist (buserelin) in human breast cancer biopsies and their distribution in relation to tumor parameters. Breast Cancer Res Treat (1993) 0.93
[Effects of routine administration of methylergometrin during puerperium on involution, maternal morbidity and lactation]. Geburtshilfe Frauenheilkd (1986) 0.93
[Possibilities and limits of pre-therapeutic neoplasm sensitivity cytostatics tests under short-term conditions]. Schweiz Med Wochenschr (1975) 0.93
Venlafaxine is superior to clonidine as treatment of hot flashes in breast cancer patients--a double-blind, randomized study. Ann Oncol (2007) 0.93
[Possible prognostic criteria for the improvement of the treatment of primary carcinoma of the breast]. Geburtshilfe Frauenheilkd (1982) 0.92
Clinical relevance of the putative stem cell marker p63 in breast cancer. Breast Cancer Res Treat (2009) 0.92